欧州症候群マルチプレックス診断市場規模、シェア、トレンド分析レポート
Market Size in USD Billion
CAGR :
% 
USD
1.17 Billion
USD
2.19 Billion
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 1.17 Billion |
 Market Size (Forecast Year) |
USD 2.19 Billion |
 CAGR |
% |
| Major Markets Players |
|
欧州症候群マルチプレックス診断市場セグメンテーション、製品タイプ別（アクセサリおよび消耗品、機器、ソフトウェアおよびサービス）、感染タイプ別（ウイルス、細菌、真菌、寄生虫、その他）、疾患別（呼吸器感染症、胃腸炎、性感染症、髄膜炎、小児感染症、免疫抑制、熱帯熱マラリア、肝炎、眼感染症、その他の疾患）、エンドユーザー別（病院、臨床検査室、医師の診療所、製薬およびバイオテクノロジー企業、研究機関、その他）、流通チャネル別（直接入札、小売販売、その他） - 2032年までの業界動向および予測
症候群性マルチプレックス診断市場分析
症候群性マルチプレックス診断市場は、迅速かつ正確な診断への需要の高まりと感染症の増加により、大幅な成長を遂げています。これらの診断プラットフォームは、複数の病原体の同時検出を可能にし、効率性と患者の転帰を改善します。主な成長要因としては、分子診断の進歩、医療インフラへの政府投資、個別化医療への意識の高まりなどが挙げられます。さらに、COVID-19パンデミックは、マルチプレックス診断システムの導入を加速させました。主要市場プレーヤーは、製品イノベーションと地域におけるプレゼンスの拡大に注力することで、市場競争力をさらに強化し、欧州のヘルスケアセクター全体の成長に貢献しています。
症候群マルチプレックス診断市場規模
欧州の症候群性マルチプレックス診断市場は、2024年の11億7,000万米ドルから2032年には21億9,000万米ドルに達し、2025年から2032年の予測期間に8.2%のCAGRで成長すると予想されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、データブリッジ市場調査がまとめた市場レポートには、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。
症候群性マルチプレックス診断市場の動向
「症候群性マルチプレックス診断におけるポイントオブケア検査の台頭」
欧州の症候群性マルチプレックス診断市場において、ポイントオブケア検査（POC）は重要なトレンドとなっています。迅速なオンサイト診断への需要の高まりにより、携帯性に優れ、使い勝手の良いマルチプレックス検査機器の導入が進んでいます。これらのPOCソリューションは、複数の病原体の迅速な検出を可能にし、タイムリーな治療決定を可能にすることで患者の転帰を改善します。このトレンドは、迅速な診断が不可欠な救急現場、地方、そしてアウトブレイク発生時に特に効果的です。小型診断技術の進歩に伴い、これらの機器はより正確で、費用対効果が高く、使い勝手も向上しており、欧州全域の医療提供における役割を大きく拡大しています。
レポートの範囲と症候群マルチプレックス診断市場のセグメンテーション
|
属性 |
症候群性マルチプレックス診断の主要市場洞察 |
|
対象セグメント |
|
|
対象国 |
ドイツ、イギリス、フランス、イタリア、スペイン、ロシア、オランダ、スイス、トルコ、ベルギー、スウェーデン、ポーランド、デンマーク、ノルウェー、フィンランド、その他のヨーロッパ諸国 |
|
主要な市場プレーヤー |
F. Hoffmann-La Roche Ltd（スイス）、DiaSorin SpA（イタリア）、BIOMÉRIEUX（フランス）、Thermo Fisher Scientific Inc.（米国）、QIAGEN（オランダ）、BD Veritor（BD）（米国）、Bio-Rad Laboratories, Inc.（米国）、Danaher Corporation（米国）、Seegene Inc.（韓国）、Hologic, Inc.（米国）、Bosch Healthcare Solutions GmbH（ドイツ）、Abbott（米国）、QuidelOrtho Corporation（米国）、Biocartis（ベルギー）、PathoFinder（オランダ）など |
|
市場機会 |
|
|
付加価値データ情報セット |
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、専門家による詳細な分析、輸入/輸出分析、価格分析、生産消費分析、PESTLE分析も含まれています。 |
症候群性マルチプレックス診断市場の定義
欧州における症候群性マルチプレックス診断市場とは、単一のサンプルから複数の病原体またはバイオマーカーを同時に検出し、感染症、がん、遺伝性疾患など様々な疾患の迅速な診断を可能にする診断検査およびプラットフォームを指します。これらの診断により、医療従事者は患者の症状の原因を迅速に特定し、治療成績の向上と医療費の削減を実現します。この市場は、分子診断における技術の進歩、より迅速で正確な検査への需要の高まり、そして個別化医療への関心の高まりによって牽引されています。
症候群性マルチプレックス診断市場の動向
ドライバー
- 感染症の蔓延率の上昇
感染症の負担はヨーロッパ全域で急速に増加しています。ウイルス、真菌、細菌、寄生虫など、様々な病原微生物が感染症に関連しています。感染症の頻度と複雑性が増すにつれ、より効率的で迅速かつ包括的な診断ツールの必要性が高まっています。症候群マルチプレックス診断は、単一の検査で複数の病原体を同時に検出することを可能にすることで解決策を提供し、新興感染症や再興感染症の出現に直面する中で、この機能はますます重要になっています。感染症の症例数の増加は症候群マルチプレックス診断率を高めており、感染症の蔓延拡大が市場の成長を牽引しています。
例えば、
2023年12月、WHOは、WHOヨーロッパ地域全体で季節性呼吸器感染症が急増しており、RSウイルス感染症、COVID-19、インフルエンザ、マイコプラズマ肺炎が入院患者数の増加につながっていると報告しました。幼児、高齢者、基礎疾患のある人は、より高いリスクに直面しています。ワクチン接種や衛生習慣を含む予防策の強化は、疾病の軽減と医療システムの負担軽減に引き続き不可欠です。
欧州全域における感染症の蔓延は、高度な診断ソリューションへの需要を牽引しています。症候群マルチプレックス診断は、1回の検査で複数の病原体を検出できるため、迅速かつ正確な疾患特定に対する高まるニーズに応えます。この傾向は市場の成長を大きく促進します。
- 分子診断技術の採用増加
分子診断は急速に進化し、疾患の検出、治療、そして研究に革命をもたらしている変革的な分野です。この技術により、感染症の正確な特定が可能になり、多くの場合、早期発見が可能になります。分子診断では、マルチプレックスPCR（ポリメラーゼ連鎖反応）パネルアッセイを用いて、様々な病原体の遺伝物質を同時に検出することで、感染症を診断します。これらのアッセイは、真菌、寄生虫、細菌、ウイルスなど、様々な微生物を複数の分類レベルにわたって特定することができます。
分子診断技術への依存が高まるにつれ、病原体検出はより包括的かつ効率的になりました。マルチプレックスPCRと高度なシーケンシング技術は、迅速かつ正確な疾患診断を可能にし、最終的には患者の転帰を改善する上で重要な役割を果たしています。正確かつタイムリーなヘルスケアソリューションへの需要の高まりは、市場におけるイノベーションを推進し、臨床意思決定の向上とより効果的な治療戦略の実現につながっています。
例えば、
2024年3月、エルゼビア社が発表した論文によると、分子診断技術、特にPCR法の普及により、感染症の診断方法が大きく変化しました。FDA承認のマルチプレックスPCRパネルは、呼吸器感染症の原因となる病原体を高感度かつ迅速に検出できるようになりました。これらのパネルは、迅速かつ正確な診断を可能にするだけでなく、抗菌薬治療の意思決定を支援し、最終的には臨床転帰の改善と患者ケアの最適化につながります。
分子診断と症候群マルチプレックス技術の利用増加は、様々な感染症に対して迅速かつ正確な結果を提供することで、医療のあり方を変革しています。これらのイノベーションは診断を効率化し、コストを削減し、治療の精度を高め、複雑な疾患への対処と世界中の患者ケアの向上に不可欠なツールとなっています。
機会
- AIと自動化の進歩
AIと自動化の進歩は、プロセスの精度、効率、および速度を向上させることで、欧州の症候群性マルチプレックス診断市場を変革しています。AI駆動型アルゴリズムは、複雑なデータセットを分析し、病原体をより正確に特定し、偽陽性または偽陰性の可能性を低減するために、症候群診断プラットフォームに統合されています。機械学習モデルは結果の解釈を合理化し、臨床意思決定を迅速化し、人的エラーを最小限に抑えます。自動化はサンプルの取り扱い、処理、および結果生成をさらに最適化し、熟練した人員への依存を減らし、ラボのワークフロー全体の効率を向上させます。AIを活用した予測分析は、疾患の早期発見とアウトブレイクの監視にも役立ち、医療提供者は積極的な対策を講じることができます。自動化を症候群性マルチプレックス診断に統合することで、一貫性のあるハイスループットの検査が保証されます。これは、多数の患者を扱う大規模な医療施設や診断センターにとって特に有益です。AIが進化し続けるにつれて、症候群診断の精度を高め、時間を短縮するAIの役割はますます重要になっています。
例えば、
2024年12月、NCBIが発表した論文によると、症候群性マルチプレックス診断の将来的な進歩は、迅速マルチプレックス分子症候群パネル（RMMSP）と予測型人工知能（AI）の統合によるもので、診断精度の向上と重症感染症患者の管理の最適化につながる可能性があります。AIを活用した自動化は、結果の解釈を向上させ、人的ミスを削減し、ワークフローを合理化することができます。AIによる自動化と分子生物学的イノベーションは診断を再定義し、効率性と精度を高めながら患者ケアの質を向上させるでしょう。この進化は、症候群性マルチプレックス診断の新たな可能性を切り開き、疾患検出と医療成果の進歩を促進するでしょう。
AIを活用したアルゴリズムは、病原体検出の改善、エラーの削減、そして臨床判断の迅速化を実現します。自動化によりサンプル処理が効率化され、熟練スタッフへの依存度が最小限に抑えられます。AIを活用した分析は、疾患の早期発見を支援し、診断能力を向上させます。これらの進歩は、効率性とアクセス性を向上させ、市場拡大を促進することで、大きなビジネスチャンスをもたらします。
- 欧州における高齢化の進行
加齢に伴い免疫力が低下し、感染症にかかりやすくなるため、高度な診断技術への需要が高まっています。これらのソリューションは、早期発見、適切な治療、そして医療成果の向上を可能にし、診断ソリューションの市場拡大とイノベーションを促進します。
例えば、
2025年2月、欧州連合（EU）の公式ウェブサイトであるユーロスタットが発表した情報によると、2024年1月1日時点のEU人口は推定4億4,930万人で、そのうち21.6%以上が65歳以上、年齢の中央値は44.7歳です。高齢化が進むにつれ、高度な診断に対する需要が高まり、市場成長の機会となっています。
南欧の人口の21%以上が既に65歳以上であり、EUの高齢者人口は2060年までにほぼ倍増すると予測されていることから、高度な診断に対する需要は高まると予想されます。加齢に伴い免疫システムが弱まり、感染症に対する感受性が高まるため、症候群性マルチプレックス診断は早期発見と適切な治療において重要な役割を果たし、市場拡大の機会を創出します。
制約/課題
- 診断製品の高コスト
小規模な医療施設やリソースが不足している施設では、財政的な制約から、これらの先進技術の導入に苦労しています。症候群マルチプレックス診断には、迅速かつ正確な診断検査のための臨床診断アッセイのための全自動ランダムアクセスマルチプレックス検査も含まれますが、これらの製品はすべてエンドユーザーにとって高価であり、市場の成長を阻害しています。
症候群マルチプレックス診断で使用される機器は、高いメンテナンスコストが必要であり、試薬や消耗品と同様に本質的に非常に高価です。このため、診断製品の高コストは、ヨーロッパの症候群マルチプレックス診断市場の成長を妨げる制約として機能しています。
- 耐性メカニズムの検出における課題
症候群パネルは迅速かつ包括的な病原体同定を可能にする一方で、最適な抗生物質療法を決定する上で極めて重要な、特定の抗菌薬耐性メカニズムを検出できないケースが多くあります。この限界により、不適切または効果のない治療のリスクが高まり、抗菌薬耐性問題の深刻化につながる可能性があります。多剤耐性菌による感染症では、タイムリーかつ的確な介入を確実に行うために、耐性マーカーの正確な特定が求められますが、一部の症候群検査ではこの情報を提供できないため、臨床意思決定が妨げられています。医療提供者は依然として従来の検査方法に頼らざるを得ない場合があり、診断時間とコストが増加し、症候群検査の全体的な効率が低下します。規制当局や医療機関が抗菌薬適正使用プログラムの重要性を強調するにつれ、耐性メカニズムを効果的に検出できる強化された症候群診断ソリューションの必要性がますます高まっています。この問題に十分に対処できないことが、症候群パネルの導入を制限し、欧州における症候群マルチプレックス診断市場の成長を鈍化させています。
例えば、
2023年2月、NCBIの記事によると、遺伝子型検査はポリン消失や排出ポンプの活性化といった非酵素耐性機構の検出に苦戦しており、感受性ではなく耐性予測のみを行っていました。検査の高コストと限られた臨床検証は、特にグラム陰性菌に対する有用性に懸念を引き起こしています。これらの限界は市場にとって大きな課題となり、正確な抗菌療法の指針となる検査の有効性を制限しています。
この市場レポートは、最近の新たな動向、貿易規制、輸出入分析、生産分析、バリューチェーンの最適化、市場シェア、国内および現地の市場プレーヤーの影響、新たな収益源の観点から見た機会分析、市場規制の変更、戦略的市場成長分析、市場規模、カテゴリー市場の成長、アプリケーションのニッチと優位性、製品承認、製品発売、地理的拡大、市場における技術革新など、詳細な情報を提供しています。市場に関する詳細情報については、Data Bridge Market Researchまでアナリストブリーフをご請求ください。当社のチームが、市場成長を実現するための情報に基づいた意思決定をお手伝いいたします。
症候群性マルチプレックス診断市場の展望
市場は、製品タイプ、感染タイプ、疾患、エンドユーザー、流通チャネルに基づいて、5つの主要なセグメントに細分化されています。これらのセグメント間の成長は、業界における成長の少ないセグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供し、コア市場アプリケーションを特定するための戦略的意思決定を支援します。
製品タイプ
- アクセサリーと消耗品
- パネル
- マルチプレックス呼吸器パネル
- マルチプレックス下気道パネル
- 肺炎（PN）/肺炎プラス（PNPLUS）パネル
- ユニベロLRTテスト
- 他の
- マルチプレックス上気道パネル
- 呼吸器ウイルスパネル
- 呼吸器病原体パネル（RPP）/呼吸器パネル2（RP2）
- 呼吸器パネルEZ（Clia-Waived）
- 呼吸器病原体フレックステスト（RPフレックス）
- その他のパネル
- マルチプレックス消化管パネル
- 消化管病原体パネル（GPP）
- 腸内細菌パネル
- 腸管ウイルスパネル
- 腸管寄生虫パネル
- 拡張腸内細菌パネル
- その他のパネル
- マルチプレックス血液培養パネル
- BCIDパネル（広域病原体同定）
- BCID-GPパネル（グラム陽性細菌パネル）
- BCID-GNパネル（グラム陰性細菌パネル）
- BCID-FPパネル（真菌病原体検出）
- グラム陽性血液培養検査（BC-GP）
- 血液培養検査（BC-GN）
- カンジダパネル
- 細菌パネル
- フェノテストBC
- その他のパネル
- マルチプレックス下気道パネル
- 髄膜炎/脳炎症候群パネル
- STI検査パネル
- その他の症候群性マルチプレックス診断パネル
- マルチプレックス呼吸器パネル
- その他
- パネル
- 楽器
- ソフトウェアとサービス
感染の種類
- バイラル
- ライノウイルス
- コロナウイルス
- ロタウイルス
- アデノウイルス
- その他
- 細菌性
- ブドウ球菌
- 肺炎
- 百日咳菌
- その他
- 真菌
- 寄生虫
- その他
病気
- 呼吸器感染症
- 胃腸炎
- 性感染症
- 髄膜炎
- 小児感染症
- 免疫抑制
- 熱帯熱マラリア
- 肝炎
- 眼感染症
- その他の病気
エンドユーザー
- 病院
- タイプ別
- 公共
- プライベート
- レベル別
- ティア1
- ティア2
- ティア3
- タイプ別
- 臨床検査室
- プライベート
- 公共
- 医師の診療所
- 製薬・バイオテクノロジー企業
- 研究機関
- その他
流通チャネル
- 直接入札
- 小売売上高
- オンライン
- オフライン
- その他
症候群性マルチプレックス診断市場の地域分析
市場は分析され、市場規模の洞察と傾向は、上記のように製品タイプ、感染タイプ、疾患、エンドユーザー、流通チャネル別に提供されます。
ドイツは、迅速かつ正確な診断結果に対する需要の高まりと市場プレーヤーによる戦略的取り組みにより、市場をリードし、急速に成長すると予測されています。
本レポートの国別セクションでは、市場の現在および将来の動向に影響を与える、各国の市場に影響を与える要因や国内市場における規制の変更についても解説しています。下流および上流のバリューチェーン分析、技術トレンド、ポーターのファイブフォース分析、ケーススタディといったデータポイントは、各国の市場シナリオを予測するための指標として活用されています。また、ヨーロッパブランドの存在と入手可能性、そして現地および国内ブランドとの競争の激しさや希少性によって直面する課題、国内関税や貿易ルートの影響についても、国別データの予測分析において考慮されています。
症候群性マルチプレックス診断市場シェア
市場競争環境は、競合他社ごとに詳細な情報を提供します。企業概要、財務状況、収益、市場ポテンシャル、研究開発投資、新規市場への取り組み、欧州におけるプレゼンス、生産拠点・設備、生産能力、強みと弱み、製品投入、製品群の幅広さ、アプリケーションにおける優位性などの詳細が含まれます。上記のデータは、各社の市場への注力分野にのみ関連しています。
症候群マルチプレックス診断市場 におけるリーダー企業は以下の通りです。
- F. ホフマン・ラ・ロシュ社（スイス）
- DiaSorin SpA（イタリア）
- ビオメリュー（フランス）
- サーモフィッシャーサイエンティフィック社（米国）
- QIAGEN（オランダ）
- BD Veritor（BD）（米国）
- バイオ・ラッド・ラボラトリーズ社（米国）
- ダナハーコーポレーション（米国）
- シージェン株式会社（韓国）
- ホロジック社（米国）
- ボッシュ・ヘルスケア・ソリューションズGmbH（ドイツ）
- アボット（米国）
- クイデルオルソコーポレーション（米国）
- ビオカルティス（ベルギー）
- PathoFinder（オランダ）
症候群性マルチプレックス診断市場の最新動向
- ロシュは2024年11月、ポセイダ・セラピューティクスを約10億米ドルで買収する契約を締結しました。この買収により、ロシュは同種細胞療法、特に腫瘍学、免疫学、神経学における能力を強化します。これにより、既製のCAR-T療法の開発を加速し、治療へのアクセスを向上させ、臨床転帰を改善することで、患者に利益をもたらすことを目指しています。この取引は2025年第1四半期に完了する予定です。
- 2024年9月、ロシュは画期的なTAGS技術を用いて12種類の呼吸器ウイルスを高スループットで同時検出する初の検査を発売しました。新しいTAGS（温度活性化シグナル生成）技術により、高スループット分子診断分析装置cobas 5800、6800、8800では、1つの患者検体から最大15種類の標的を同時に検出することが可能になりました。
- 2023年3月、ロシュ社は、米国FDAの腫瘍医薬品諮問委員会が、未治療のびまん性大細胞型B細胞リンパ腫（DLBCL）に対するポリビーとR-CHPの併用療法を承認したと発表しました。この併用療法は、標準的なR-CHOP療法と比較して無増悪生存期間の有意な延長を示し、DLBCL患者にとって有望な第一選択治療選択肢となりました。この決定は、過去20年間治療の進歩が限られていたこの悪性度の高い癌の患者転帰の改善につながると期待されます。
- 2022年3月、MDiaSorinのLuminexは、便検体中の16種類の細菌、ウイルス、寄生虫病原体を検出するマルチプレックス検査であるxMAP NxTAG消化管病原体パネル（GPP）でCEマークを取得しました。MAGPIXシステム向けに設計されたこの検査は、即日結果を提供し、欧州全域の臨床検査室における迅速な診断、抗生物質管理、ハイスループット検査の向上に貢献します。
- 2023年5月、DiaSorin SpAはMeMedとのパートナーシップを強化し、イタリアにおけるMeMed BV検査の販売契約を締結しました。AIを搭載したこの検査は、細菌感染とウイルス感染を鑑別し、抗菌薬投与の判断を支援します。世界的に検証されており、患者管理を強化し、抗菌薬耐性（AMR）対策を支援します。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 INDUSTRY INSIGHTS
4.4 TECHNOLOGY ROADMAP
5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF INFECTIOUS DISEASES
6.1.2 RISING ADOPTION OF MOLECULAR DIAGNOSTICS TECHNIQUES
6.1.3 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS
6.1.4 INCREASING DEMAND FOR FAST AND ACCURATE DIAGNOSTIC RESULTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS
6.2.2 VARIABILITY IN TEST PERFORMANCE ACROSS DIFFERENT MANUFACTURERS
6.3 OPPORTUNITIES
6.3.1 ADVANCEMENTS IN AI & AUTOMATION
6.3.2 RISING AGING POPULATION IN EUROPE
6.3.3 RISING HOSPITAL-ACQUIRED INFECTIONS
6.4 CHALLENGES
6.4.1 CHALLENGES IN DETECTING RESISTANCE MECHANISMS
6.4.2 LACK OF MEDICAL PROFESSIONALS IN EUROPE
7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 ACCESSORIES & CONSUMABLES
7.2.1 PANELS
7.2.1.1 MULTIPLEX RESPIRATORY PANELS
7.2.1.1.1 MULTIPLEX LOWER RESPIRATORY PANELS
7.2.1.1.2 PNEUMONIA (PN)/PNEUMONIA PLUS (PNPLUS) PANELS
7.2.1.1.3 UNYVERO LRT TEST
7.2.1.1.4 OTHER
7.2.1.2 MULTIPLEX UPPER RESPIRATORY PANELS
7.2.1.2.1 RESPIRATORY VIRAL PANEL
7.2.1.2.2 RESPIRATORY PATHOGEN PANEL (RPP)/RESPIRATORY PANEL 2 (RP2)
7.2.1.2.3 RESPIRATORY PANEL EZ (CLIA-WAIVED)
7.2.1.2.4 RESPIRATORY PATHOGENS FLEX TEST (RP FLEX)
7.2.1.2.5 OTHER PANELS
7.2.1.3 MULTIPLEX GI PANELS
7.2.1.3.1 GI PATHOGEN PANEL (GPP)
7.2.1.3.2 ENTERIC BACTERIAL PANEL
7.2.1.3.3 ENTERIC VIRAL PANEL
7.2.1.3.4 ENTERIC PARASITE PANEL
7.2.1.3.5 EXTENDED ENTERIC BACTERIAL PANEL
7.2.1.3.6 OTHER PANELS
7.2.1.4 MULTIPLEX BLOOD CULTURE PANELS
7.2.1.4.1 BCID PANEL (BROAD-SPECTRUM PATHOGEN IDENTIFICATION)
7.2.1.4.2 BCID-GP PANEL (GRAM-POSITIVE BACTERIA PANEL)
7.2.1.4.3 BCID-GN PANEL (GRAM-NEGATIVE BACTERIA PANEL)
7.2.1.4.4 BCID-FP PANEL (FUNGAL PATHOGEN DETECTION)
7.2.1.4.5 GRAM-POSITIVE BLOOD CULTURE TEST (BC-GP)
7.2.1.4.6 BLOOD CULTURE TEST (BC-GN)
7.2.1.4.7 CANDIDA PANEL
7.2.1.4.8 BACTERIA PANEL
7.2.1.4.9 PHENOTEST BC
7.2.1.4.10 OTHER PANELS
7.2.1.5 MENINGITIS/ENCEPHALITIS SYNDROMIC PANEL
7.2.1.6 STI TEST PANELS
7.2.1.7 OTHER SYNDROMIC MULTIPLEX DIAGNOSTIC PANELS
7.3 INSTRUMENTS
7.4 SOFTWARE & SERVICES
8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE
8.1 OVERVIEW
8.2 VIRAL
8.2.1 RHINOVIRUS
8.2.2 CORONAVIRUS
8.2.3 ROTAVIRUS
8.2.4 ADENOVIRUS
8.2.5 OTHERS
8.3 BACTERIAL
8.3.1 STAPHYLOCOCCUS
8.3.2 PNEUMONIA
8.3.3 BORDETELLA PERTUSSIS
8.3.4 OTHERS
8.4 FUNGAL
8.5 PARASITES
8.6 OTHERS
9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE
9.1 OVERVIEW
9.2 RESPIRATORY INFECTIONS
9.3 GASTROENTERITIS
9.4 SEXUALLY TRANSMITTED INFECTIONS
9.5 MENINGITIS
9.6 CHILDHOOD INFECTIONS
9.7 IMMUNOSUPPRESSION
9.8 TROPICAL FEVER
9.9 HEPATITIS
9.1 EYE INFECTIONS
9.11 OTHER DISEASES
10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 BY TYPE,
10.2.1.1 PRIVATE
10.2.1.2 PUBLIC
10.2.2 BY LEVEL
10.2.2.1 TIER 1
10.2.2.2 TIER 2
10.2.2.3 TIER 3
10.3 CLINICAL LABORATORIES
10.3.1 BY TYPE
10.3.1.1 PRIVATE
10.3.1.2 PUBLIC
10.4 PHYSICIAN OFFICES
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.6 RESEARCH INSTITUTES
10.7 OTHERS
11 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.3.1 ONLINE
11.3.2 OFFLINE
11.4 OTHERS
12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRIES
12.1 EUROPE
12.1.1 GERMANY
12.1.2 U.K.
12.1.3 FRANCE
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 NETHERLANDS
12.1.8 TURKEY
12.1.9 BELGIUM
12.1.10 SWEDEN
12.1.11 POLAND
12.1.12 DENMARK
12.1.13 NORWAY
12.1.14 FINLAND
12.1.15 REST OF EUROPE
13 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENTS
15.2 DIASORIN S.P.A
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 SOULUTION PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 BIOMERIEUX
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS/NEWS
15.4 THERMO FISHER SCIENTIFIC INC.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENTS
15.5 QIAGEN
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 ABBOTT
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS/NEWS
15.7 BD VERITOR (BD)
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 BIOCARTIS
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BIO-RAD LABORATORIES, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 BOSCH HEALTHCARE SOLUTIONS GMBH
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 DANAHER CORPORATION
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 HOLOGIC, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS/NEWS
15.13 PATHOFINDER
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 QUIDELORTHO CORPORATION
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS/NEWS
15.15 SEEGENE INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表のリスト
TABLE 1 COST OF MULTIPLEX DIAGNOSTIC PRODUCT IN USD
TABLE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 3 EUROPE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 4 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 6 EUROPE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 7 EUROPE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 10 EUROPE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 11 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 13 EUROPE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 14 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 16 EUROPE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 17 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 18 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 19 EUROPE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 EUROPE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 22 EUROPE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 25 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 26 EUROPE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 27 EUROPE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 29 EUROPE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 31 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 GERMANY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 34 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 35 GERMANY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 36 GERMANY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 37 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 38 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 39 GERMANY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 40 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 42 GERMANY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 43 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 45 GERMANY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 46 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 47 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 48 GERMANY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 49 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 50 GERMANY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 GERMANY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 52 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 53 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 54 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 55 GERMANY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 56 GERMANY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 GERMANY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 58 GERMANY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 59 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 60 U.K. ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 63 U.K. PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 64 U.K. MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 67 U.K. MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 68 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 69 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 70 U.K. MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 71 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 73 U.K. MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 74 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 76 U.K. MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 77 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 U.K. VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 U.K. BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 81 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 82 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 83 U.K. HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 84 U.K. CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 U.K. SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 86 U.K. RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 87 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 FRANCE ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 91 FRANCE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 92 FRANCE MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 94 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 95 FRANCE MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 96 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 98 FRANCE MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 99 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 101 FRANCE MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 102 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 104 FRANCE MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 105 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 FRANCE VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 FRANCE BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 109 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 110 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 FRANCE HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 112 FRANCE CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 113 FRANCE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 114 FRANCE RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 115 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 ITALY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 119 ITALY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 120 ITALY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 122 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 123 ITALY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 124 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 126 ITALY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 127 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 129 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 130 ITALY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 132 ITALY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 133 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 ITALY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 ITALY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 137 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 138 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 139 ITALY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 140 ITALY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 ITALY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 142 ITALY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 143 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 SPAIN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 145 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 146 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 147 SPAIN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 148 SPAIN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 149 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 151 SPAIN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 152 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 154 SPAIN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 155 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 156 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 157 SPAIN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 158 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 159 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 160 SPAIN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 161 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 162 SPAIN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 SPAIN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 165 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 166 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 SPAIN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 168 SPAIN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 SPAIN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 170 SPAIN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 171 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 172 RUSSIA ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 173 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 175 RUSSIA PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 176 RUSSIA MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 179 RUSSIA MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 180 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 181 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 182 RUSSIA MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 183 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 185 RUSSIA MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 186 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 187 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 188 RUSSIA MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 189 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 RUSSIA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 191 RUSSIA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 192 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 193 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 194 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 RUSSIA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 196 RUSSIA CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 RUSSIA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 198 RUSSIA RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 200 NETHERLANDS ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 201 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 NETHERLANDS PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 203 NETHERLANDS MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 204 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 206 NETHERLANDS MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 207 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 NETHERLANDS MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 209 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 210 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 211 NETHERLANDS MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 212 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 214 NETHERLANDS MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 215 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 216 NETHERLANDS VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 NETHERLANDS BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 219 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 220 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 NETHERLANDS HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 222 NETHERLANDS CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 NETHERLANDS SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 224 NETHERLANDS RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 SWITZERLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 228 SWITZERLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 229 SWITZERLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 230 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 231 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 232 SWITZERLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 233 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 235 SWITZERLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 236 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 237 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 238 SWITZERLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 239 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 241 SWITZERLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 242 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 243 SWITZERLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 244 SWITZERLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 245 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 246 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 247 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 SWITZERLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 249 SWITZERLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 SWITZERLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 251 SWITZERLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 253 TURKEY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 254 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 256 TURKEY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 257 TURKEY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 258 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 259 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 260 TURKEY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 261 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 262 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 263 TURKEY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 264 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 TURKEY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 266 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 267 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 268 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 269 TURKEY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 270 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 TURKEY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 TURKEY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 274 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 275 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 276 TURKEY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 277 TURKEY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 278 TURKEY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 279 TURKEY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 280 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 281 BELGIUM ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 282 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 284 BELGIUM PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 285 BELGIUM MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 286 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 288 BELGIUM MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 289 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 290 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 291 BELGIUM MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 292 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 293 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 294 BELGIUM MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 295 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 296 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 297 BELGIUM MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 298 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 BELGIUM VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 BELGIUM BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 301 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 302 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 303 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 BELGIUM HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 305 BELGIUM CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 BELGIUM SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 307 BELGIUM RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 309 SWEDEN ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 312 SWEDEN PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 313 SWEDEN MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 315 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 316 SWEDEN MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 317 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 319 SWEDEN MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 320 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 322 SWEDEN MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 323 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 325 SWEDEN MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 326 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 SWEDEN VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 SWEDEN BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 329 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 330 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 331 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 332 SWEDEN HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 333 SWEDEN CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 334 SWEDEN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 335 SWEDEN RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 336 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 POLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 338 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 339 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 340 POLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 341 POLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 342 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 344 POLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 345 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 346 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 347 POLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 348 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 349 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 350 POLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 351 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 352 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 353 POLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 354 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 355 POLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 POLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 358 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 359 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 POLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 361 POLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 POLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 363 POLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 365 DENMARK ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 366 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 367 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 368 DENMARK PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 369 DENMARK MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 371 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 372 DENMARK MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 373 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 374 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 375 DENMARK MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 376 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 377 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 378 DENMARK MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 379 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 380 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 381 DENMARK MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 382 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 383 DENMARK VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 384 DENMARK BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 385 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 386 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 387 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 388 DENMARK HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 389 DENMARK CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 390 DENMARK SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 391 DENMARK RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 392 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 NORWAY ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 394 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 396 NORWAY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 397 NORWAY MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 398 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 400 NORWAY MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 401 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 402 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 403 NORWAY MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 404 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 405 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 406 NORWAY MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 407 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 409 NORWAY MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 410 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 411 NORWAY VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 412 NORWAY BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 413 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 414 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 415 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 NORWAY HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 417 NORWAY CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 NORWAY SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 419 NORWAY RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 420 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 421 FINLAND ACCESSORIES & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 423 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 424 FINLAND PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 425 FINLAND MULTIPLEX RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 426 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 427 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 428 FINLAND MULTIPLEX LOWER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 429 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 430 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 431 FINLAND MULTIPLEX UPPER RESPIRATORY PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 432 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 433 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 434 FINLAND MULTIPLEX GI PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 435 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 436 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (VOLUME IN THOUSAND UNITS)
TABLE 437 FINLAND MULTIPLEX BLOOD CULTURE PANELS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (ASP IN USD/UNITS)
TABLE 438 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2032 (USD THOUSAND)
TABLE 439 FINLAND VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 FINLAND BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 441 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2032 (USD THOUSAND)
TABLE 442 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 443 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 444 FINLAND HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY LEVEL, 2018-2032 (USD THOUSAND)
TABLE 445 FINLAND CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 446 FINLAND SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 447 FINLAND RETAIL SALES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 448 REST OF EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
図表一覧
FIGURE 1 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
FIGURE 2 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DROC ANALYSIS
FIGURE 4 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COUNTRY-WISE MARKET ANALYSIS
FIGURE 5 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS.
FIGURE 7 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION
FIGURE 11 THREE SEGMENTS COMPRISE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCT TYPE (2024)
FIGURE 12 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 RISING PREVALENCE OF INFECTIOUS DISEASES IS EXPECTED TO DRIVE THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 ACCESSORIES & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 16 DROC ANALYSIS
FIGURE 17 TOTAL NUMBER OF CASES OF TUBERCULOSIS IN 2022 AND 2023
FIGURE 18 TOTAL NUMBER OF CASES OF SEXUALLY TRANSMITTED INFECTIONS (STIS)
FIGURE 19 INCREASE IN THE SHARE OF THE POPULATION AGED 65 YEARS AND OVER BETWEEN 2014 AND 2024
FIGURE 20 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2024
FIGURE 21 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 22 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 23 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2024
FIGURE 25 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 26 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, CAGR (2025-2032)
FIGURE 27 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, LIFELINE CURVE
FIGURE 28 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2024
FIGURE 29 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2025 TO 2032 (USD THOUSAND)
FIGURE 30 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, CAGR (2025-2032)
FIGURE 31 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, LIFELINE CURVE
FIGURE 32 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2024
FIGURE 33 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 34 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, CAGR (2025-2032)
FIGURE 35 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 37 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 38 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 39 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SNAPSHOT, 2024
FIGURE 41 EUROPE SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY SHARE 2024 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
